Rapport Therapeutics Inc
(RAPP)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | RAPP | AZN | AMGN | GILD | BMY |
| Company | Rapport Therapeutics Inc | Astrazeneca Plc | Amgen Inc | Gilead Sciences Inc | Bristol-Myers Squibb Company |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NASDAQ | NASDAQ | NYSE |
| Open | 26.70 | 191.80 | 380.70 | 151.85 | 61.37 |
| High | 26.90 | 192.76 | 384.62 | 153.00 | 61.63 |
| Low | 25.78 | 189.73 | 373.49 | 150.39 | 60.60 |
| Latest | 27.21 | 190.41 | 375.01 | 151.39 | 61.20 |
| Change | +0.12 | -2.62 | -9.31 | -1.11 | -0.79 |
| % Change | +0.44% | -1.36% | -2.42% | -0.73% | -1.27% |
| Volume | 40,126 | 925,636 | 776,384 | 1,732,505 | 3,099,667 |
| 20-Day Average Volume | 325,047 | 4,720,035 | 3,013,818 | 7,903,558 | 13,136,540 |
| Previous Close | 27.09 | 193.03 | 384.32 | 152.50 | 61.99 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 26.85 | 187.16 | 345.62 | 136.04 | 56.27 |
| 20-Day Raw Stochastic | 39.71% | 75.65% | 87.62% | 95.28% | 91.77% |
| 20-Day Relative Strength | 47.54 | 55.11 | 66.93 | 75.10 | 70.70 |
| Weighted Alpha | +13.90 | +33.96 | +37.73 | +54.85 | +26.10 |
| Today's Opinion | 8% Buy | 100% Buy | 100% Buy | 100% Buy | 100% Buy |
| Previous Opinion | 24% Buy | 100% Buy | 100% Buy | 100% Buy | 100% Buy |
| Last Month's Opinion | 80% Buy | 100% Buy | 96% Buy | 40% Buy | 88% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | -3.73% since 02/02/26 | +0.90% since 02/02/26 | +9.39% since 02/02/26 | +6.06% since 02/02/26 | +9.77% since 02/02/26 |
| Low | 25.21 on 02/05/26 | 183.63 on 02/03/26 | 338.59 on 02/03/26 | 142.03 on 02/03/26 | 55.49 on 02/03/26 |
| High | 28.59 on 02/03/26 | 193.97 on 02/06/26 | 385.12 on 02/06/26 | 153.13 on 02/06/26 | 62.05 on 02/06/26 |
| 1-Month | |||||
| %Chg | -7.75% since 01/09/26 | +0.42% since 01/09/26 | +15.62% since 01/09/26 | +25.14% since 01/09/26 | +9.83% since 01/09/26 |
| Low | 25.21 on 02/05/26 | 178.08 on 01/21/26 | 319.79 on 01/13/26 | 119.63 on 01/12/26 | 53.54 on 01/21/26 |
| High | 29.00 on 01/12/26 | 193.97 on 02/06/26 | 385.12 on 02/06/26 | 153.13 on 02/06/26 | 62.05 on 02/06/26 |
| 3-Month | |||||
| %Chg | +4.11% since 11/07/25 | +12.38% since 11/07/25 | +17.75% since 11/07/25 | +27.52% since 11/07/25 | +31.40% since 11/07/25 |
| Low | 23.75 on 11/17/25 | 171.69 on 11/10/25 | 312.39 on 12/11/25 | 116.88 on 01/05/26 | 45.26 on 11/20/25 |
| High | 32.36 on 12/23/25 | 193.97 on 02/06/26 | 385.12 on 02/06/26 | 153.13 on 02/06/26 | 62.05 on 02/06/26 |
| 6-Month | |||||
| %Chg | +83.61% since 08/08/25 | +29.23% since 08/08/25 | +30.81% since 08/08/25 | +26.92% since 08/08/25 | +33.51% since 08/08/25 |
| Low | 13.86 on 08/19/25 | 145.79 on 09/25/25 | 269.77 on 09/26/25 | 108.46 on 10/02/25 | 42.52 on 10/29/25 |
| High | 42.27 on 09/08/25 | 193.97 on 02/06/26 | 385.12 on 02/06/26 | 153.13 on 02/06/26 | 62.05 on 02/06/26 |
| Key Statistics | |||||
| Market Capitalization, $K | 1,291,136 | 299,371,776 | 206,949,024 | 189,203,696 | 126,196,336 |
| Shares Outstanding, K | 47,661 | 1,550,908 | 538,481 | 1,240,680 | 2,035,753 |
| Annual Sales | 0 | 54,073,000,000 | 33,424,000,000 | 28,754,000,000 | 48,300,000,000 |
| Annual Net Income | -78,310,000 | 7,035,000,000 | 4,090,000,000 | 480,000,000 | -8,948,000,000 |
| Last Quarter Sales | 0 | 15,191,000,000 | 9,557,000,000 | 7,769,000,000 | 12,222,000,000 |
| Last Quarter Net Income | -26,930,000 | 2,533,000,000 | 3,216,000,000 | 3,052,000,000 | 2,201,000,000 |
| 60-Month Beta | 1.63 | 0.34 | 0.46 | 0.36 | 0.29 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.71 on 11/06/25 | 1.19 on 11/06/25 | 5.29 on 02/03/26 | 2.47 on 10/30/25 | 1.26 on 02/05/26 |
| Latest Earnings Date | 03/10/26 | 02/10/26 | 05/07/26 | 02/10/26 | 04/23/26 |
| Most Recent Dividend | N/A | 0.505 on 08/08/25 | 2.380 on 11/21/25 | 0.790 on 12/15/25 | 0.630 on 01/02/26 |
| Next Ex-Dividends Date | N/A | 08/08/25 | 02/13/26 | 12/15/25 | 01/02/26 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 20.48 | 16.83 | 18.24 | 9.68 |